Quantification of growth factors in allogenic bone grafts extracted with three different methods by Wildemann, B. et al.
Abstract
Background Bony allografts are used for
defect ﬁlling. A reliable sterilization method is
the peracetic acid–ethanol sterilization proce-
dure (PES). Several studies showed the antimi-
crobiological efﬁcacy of this method. Aim of
this study was the quantiﬁcation of growth
factors necessary for bone formation in PES
sterilized allografts (n = 9).
Methods To extract the growth factors from
the tissue three different methods were used:
(a) use of collagenase 1 for extraction, (b)
incubation of the material in a proteinase
inhibitor cocktail (Complete), and (c) extraction
with guanidine HCl. The supernatants from the
different methods were analyzed for the total
protein concentration and different growth
factors.
Results The extraction with guanidine HCl re-
sultedinthehighestamountofproteinmeasurable
inthesupernatantsofthesamples.Forcomparison
of the individual growth factor values the results
were normalized to the protein content. The
highest growth factor amount/protein was detect-
able for BMP-2 using the GndHCL method
followed by FGFa, IGF-I, TGF-b1, VEGF, and
PDGF. Comparing the three extraction methods,
signiﬁcant differences were measured for the
individual growth factor content.
Conclusion PES sterilized bony allografts con-
tain several growth factors. Depending on the
extraction method, the quantity of the analyzed
growth factors varies.
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Bone defects are a major problem in orthopaedic
surgery. The gold standard for defect ﬁlling is the
use of autogenic bony material. Due to compli-
cations associated with the harvesting of auto-
genic material (Sasso et al. 2005; Silber et al.
2003; Skaggs et al. 2000), allogenic or alloplastic
materials might be an alternative grafting
material. In the ideal case, this material is bio-
compatible, not infective, resorbable, osteocon-
ductive, and osteoinductive. Osteoconduction
means that bone growth onto a surface or into a
given three-dimensional structure (Albrektsson
and Johansson 2001). Osteoinduction is a neces-
sary process for bone formation because it
describes the recruitment of undifferentiated
pluripotent cells and their stimulation to differ-
entiate into bone forming cells (Albrektsson and
Johansson 2001). Allogenic grafts fulﬁl the de-
mand of osteoconductivity. These grafts can
either be cancellous or cortical in nature. Both
variants allow the revascularization and the
migration of bone forming and resorbing cells
onto and into the tissue (Ripamonti et al. 1993;
Stiehl 2004; Taira et al. 2004). Therefore, the
graft serves as a structure for new bone forma-
tion. Osteoinduction is a further necessary pro-
cess for optimal graft ingrowth. Growth factors
such as IGF-I, TGF-b1, VEGF, etc, are osteoin-
ductive and promote bone formation (Bolander
1992; Lane et al. 1999; Lind and Bunger 2001;
Schliephake 2002). The tissue processing of the
grafts such as sterilization, however, might inﬂu-
ence the growth factors.
Methods for inactivation of bacteria and viruses
use ethylene oxide (EtO), gamma irradiation
(Bright1987)orthermaltreatmentwithmoistheat
(Hofmann et al. 1996; Knaepler et al. 1994). A
possible reduction of the osteoinductive potential
by ethylene oxide sterilization is under contro-
versial discussion (Aspenberg and Lindqvist 1998;
Thoren and Aspenberg 1995; Zhang et al. 1997).
Starting in 1967 EtO was replaced by the use of
beta-propiolactone (Geesink 2002) and gamma
radiation of 25 kGy (International Atomic Energy
Agency (IAEA) 1990). Gamma irradiation, how-
ever,mightpromotetheformationoftoxicradicals
and have a negative effect on biochemical
parameters(Moreauet al.2000;Rock1991).Since
beta-propiolactone sterilization also showed, to an
increasing extent, problems such as toxicity, a new
process on a low-pressure basis, i.e., peracetic
acid–ethanol sterilization (PES) (Sprossig and
Mucke 1968; Wutzler and Sauerbrei 2000), was
introduced (von Versen et al. 1992). The PES
treatment for allogenic avital bony tissue is a reli-
able sterilization method (Pruss et al. 2003).
Several studies validated the efﬁcacy of this
method on selected viruses, bacteria, fungi, and
spores and compared this method with other
sterilization method (Pruss et al. 2001; Pruss et al.
2003).
Haynert, Thielecke et al., and Kuhls et al.
studied in the framework of clinical feasibility
studies the osteoinductive capabilities or inte-
grating ratios of PES sterilized dematerialized
bone matrix (DBM) (Haynert 1990; Kuhls et al.
2001; Thielicke et al. 1990). It was reported
unanimously that the PES does not cause any
signiﬁcant reductions of the osteoinductive effects
and that the transplanted DBM shows excellent
integrating results. A retrospective report of
clinical experience of the years 1997–2001 on the
overall scope of tissue grafts (total of 16,823
transplants) showed a good up to very good
clinical efﬁcacy without clinically relevant side
effects (Pruss et al. 2002). Goal of the present
study was to quantify growth factors necessary
for bone formation in PES sterilized allograft
material using different extraction methods.
Materials and methods
Samples
Allografts (n = 9) were provided by the tissue
bank of the Charite ´. Potential bone tissue donors
were clinically examined for a variety of infectious
diseases. The approved material was processed
with the PES procedure (PES) for allogenic avital
bone transplants as described previously (Pruss
et al. 2001). Brieﬂy, the chloroform–methanol
defatted bony material was incubated at low
pressure (200 mbar) at room temperature for 4 h
underagitationin2% peracetic acid, 96% ethanol,
Aqua (2:1:1).
108 Cell Tissue Banking (2007) 8:107–114
123Demographic data of the donors: 5 male, age:
43 ± 19.4 (18–67 years); 4 female, age: 52.3 ± 10.6
(40–66 years).Fromalldonorsthefemorawereused.
Sample preparation
The sterile allografts were pulverized using a
cooled mill (Retsch, Germany). The homoge-
nized bony material was diluted in accordance to
one the following procedures.
(a) Collagenase Extraction: One gram sample
was placed in 15 ml centrifuge tubes, and
covered with 3 ml of 20 mM Tris buffer plus
20 U/ml Collagenase Type 1. After incuba-
tion at 37C in a shaking water bath over
night the tubes were centrifuged for 20 min
at 12,000 rpm. After centrifugation, the
supernatant was dialyzed against aqua dest
over night at 4C with three changes and
thereafter stored at – 80C (modiﬁed after
(Blum et al. 2004; Laitinen et al. 1997)).
(b) Proteinase Inhibitor (Complete): Two gram
sample was incubated for 2 h with 5 ml
Proteinase inhibitor (Complete, Roche,
Mannheim, Germany) at 4C. After extrac-
tion the samples were centrifuged by
12,000 rpm for 10 min and the supernatant
was stored at – 80C.
(c) Guanidine HCl/EDTA method: Thirty mil-
ligram of sample were placed in 1.5 ml
Eppendorf tubes with 1.9 ml 4 M Guanidine
HCl, 50 mM EDTA in 50 ml Tris pH 7.4
plus 5 mM benzamidine-HCl, 1 mM phen-
ylmethylsulfonyl, and 0.1 mM aminocaproic
acid. The samples were dialyzed against
aqua dest at 4C for 24 h with four changes
(modiﬁed after (Pepene et al. 2004; Sampath
and Reddi 1981)).
After extraction the samples were centrifuged
by 12,000 rpm and the supernatant was stored at
–8 0 C.
Protein and growth factor quantiﬁcation
To quantify the total protein concentration a
Coomassie Plus Protein Assay (Pierce, Perbio
Science GmbH, Germany) was used. IGF-I, TGF-
b1, BMP-2, BMP-4, PDGFbb, FGFa, FGFb, and
VEGF concentration in the extracts were quan-
tiﬁed using ELISA-methods (all kits were ob-
tained from R&D-Systems, Wiesbaden,
Germany). The analyses were performed ac-
cording to the instructions of the manufacturer.
Brieﬂy, samples and standards were added to
growth factor antibody coated 96 well plates.
After incubation and removal of the unbound
substances an enzyme coupled secondary anti-
body was added. This step was followed by a
further washing step and incubated with a sub-
strate. The color reaction was stopped and the
optical density measured at the appropriate
wavelength. If necessary, samples were pretreated
as mentioned in the manufactures instructions.
Statistical analysis
The values are reported as mean ± SD. In the
case that no growth factor value was determined
with the ELISA, the sample was excluded from
further statistical evaluation (see Table 1). Com-
parison of data was performed using ANOVA for
global comparison and controlled with Bonfer-
roni correction for multiple testing. Statistical
differences were deﬁned at a 95% conﬁdence
level. SPSS (release 12.0; SPSS Inc. Chicago,
Illinois) software supported statistical evaluation.
Results
From eight analyzed growth factors were seven
detectable in the allografts (FGFb was not
detectable). From the detectable seven growth
factors not all the factors were measurable in
Table 1 Number of
allografts in which the
growth factors were
detectable
Protein BMP-2 IGF-I VEGF FGFa TGF-b1 PDGF BMP-4
Collagenase 9 2 8 4 6 3 7 0
Complete 9 2 9 6 8 1 6 7
GndHCl 9 9 9 5 8 2 8 0
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123every allograft (Table 1). A relation of these
differences in respect to donor age or gender was
not accessible.
Total protein
The nine allografts were homogenized in the
same way. The proteins were extracted using
three different methods: extraction with Colla-
genase digestion, incubation in PBS with pro-
teinase inhibitor (Complete), or with the
guanidine HCl method. Signiﬁcantly more pro-
tein per g tissue was extracted using the guanidine
HCl method (Fig. 1). Almost 10 mg protein was
extracted from 1 g sample with this method. This
is 24 times more compared to the Complete and
39 times more compared to the Collagenase
method. Due to the differences in the extraction
efﬁcacy, the following growth factor data were
normalized to the protein content of the samples.
Quantiﬁcation of growth factors
The growth factor BMP-4 was only detectable
after the extraction with the Complete method. In
seven of nine samples BMP-4 was measurable
with an average value of 0.17 pg/lg protein and a
SD of 0.06 pg/lg (see Table 2, per g allograft).
The highest growth factor value compared to
total protein was detectable for BMP-2. After
GndHCl extraction 450 ± 273 pg BMP-2 per lg
protein were measured (Fig. 2). This value was
dramatically higher compared to the value as-
sessed after Collagenase (1.5 ± 0.7 pg/lg) or
Complete extraction (1.9 ± 1.07 pg/lg). Using the
GndHCl method in all nine allografts BMP-2 was
detectable whereas in both other methods only in
Protein
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Fig. 1 Protein content per gram sample. Signiﬁcantly
more protein was extracted from the samples after
GndHCl extraction compared to both other methods,
*P < 0.001
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123two allografts, therefore, the difference was not
signiﬁcant. The level of IGF-I and VEGF were
signiﬁcantly higher after Collagenase extraction
compared to the GndHCl method (Figs. 3, 4).
In contrast, FGFa revealed a signiﬁcantly higher
value after GndHCl extraction compared to both
other methods (Fig. 5). No signiﬁcant differences
were measurable for the growth factors TGF-b1
and PDGF (Figs. 6, 7). TGF-b1 was detectable
only in one to three of nine samples with the three
different methods. Not all method extracted
TGF-b1 from the same samples (Table 1).
Discussion
One important question using allografts for bone
defect ﬁlling is the content of growth factors in
the graft material. Therefore, aim of this study
was the quantiﬁcation of growth factors in PES
sterilized allografts.
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Fig. 2 Quantiﬁcation of BMP-2 [pg/lg Protein] in allo-
grafts using three different extraction methods. The BMP-
2 content is correlated to the total protein content of the
samples. Using the Collagenase or the Complete Method
in only two of nine samples was BMP-2 detectable
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Fig. 3 Quantiﬁcation of IGF-I [pg/lg Protein] in allografts
using three different extraction methods, *P = 0.003
compared to GndHCl
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Fig. 4 Quantiﬁcation of VEGF [pg/lg Protein] in allo-
grafts using three different extraction methods, *P = 0.014
compared to GndHCl
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Fig. 5 Quantiﬁcation of FGFa [pg/lg Protein] in allografts
using three different extraction methods, *P < 0.001
compared to both methods
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Fig. 6 Quantiﬁcation of TGF-b1 [pg/lg Protein] in allo-
grafts using three different extraction methods
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Fig. 7 Quantiﬁcation of PDGF [pg/lg Protein] in allo-
grafts using three different extraction methods
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123From the eight investigated growth factors se-
ven were detectable in the allografts: BMP-2,
BMP-4, IGF-I, VEGF, FGFa, TGF-b1, and
PDGF. FGFb was not detectable in any sample.
Three different methods for protein extraction
were used which also differ in the handling and the
preparation time. The elution of the homogenized
bony material in PBS plus proteinase inhibitor
(Complete) is very easy and fast. The two other
methods—collagenasedigestion(Blumet al.2004;
Laitinen et al. 1997) and guanidine HCl extraction
(Pepene et al. 2004; Sampath and Reddi
1981)—are time consuming and laborious. Signiﬁ-
cant differences were found in the amount of ex-
tracted total protein. The highest value was
obtained with the guanidine HCl method (app.
10 mg/g sample). With the two other methods sig-
niﬁcant but comparable lower values were mea-
sured. Differences were also detectable in the
amount of the measured growth factors. To over-
come the differences in the extraction efﬁcacy, we
normalized the growth factor content to the total
protein value obtained by each method. BMP-4,
however, was only detectable after PBS and pro-
teinaseinhibitorextraction(Completemethod).A
nearly comparable succession of growth factors
wasobtainedwiththethreemethodsbutsigniﬁcant
differences were measurable in the value of the
individual growth factors depending on the
extraction method. The highest BMP-2 value was
obtained after GndHCl extraction. The GndHCl
extraction showed also for FGFa the highest
extraction value compared to both other methods.
UsingtheCollagenasedigestion,IGF-IandVEGF
were extractable in a signiﬁcantly higher value
compared to the GndHCl method. These results
clearly demonstrate the importance of the extrac-
tionmethod.Acomparisonofgrowthfactorvalues
is only possible, when the same extraction proto-
cols were used.
The study shows that using the guanidine
extraction method signiﬁcantly more protein can
be extracted. This method however is time con-
suming and needs much more different chemicals.
For a comparison of growth factors or different
materials we can recommend the easy and fast
proteinase method. This is the ﬁrst study that
quantiﬁed growth factors in allografts. The limi-
tations of the study are that it is hardly possible to
make a conclusion, if these detected amounts are
sufﬁcient to induce new bone formation and that
the bioactivity was not tested. The quantiﬁcation
with ELISA method gives no information con-
cerning the bioactivity of the growth factors. A
2005 published study by Honsawek, however,
showed a good correlation between the osteoin-
ductivity of demineralized bone matrix (DBM)
and the BMP-4 content measured by ELISA
method (Honsawek et al. 2005). DBMs with high
BMP-4 level demonstrated the highest osteoin-
ductivity in the mouse bioassay. In addition, sev-
eral studies were able to demonstrate an
osteoinductive potential of allografts (Kubler
et al. 1995; Lohmann et al. 2001; Pinholt and
Solheim 1998). Hansen et al. used PES-sterilized
demineralized bone matrix for ﬁlling of critical
size craniotomy defects. Compared to the unﬁlled
defects, they describe bone defect bridging by
newly formed woven bone with incorporated
DBM residues on day 84 (Hansen et al. 2001).
These results, taken together with the quantiﬁ-
cation of growth factors in human allografts,
support the hypothesis that allografts have an
osteoinductive potential and promote the graft
incorporation. However, further in vivo and in
vitro investigation on the bioactivity of the de-
tected growths factors in the allograft should be
performed.
Acknowledgment The authors gratefully thank Sven
Schurig for tissue harvesting and preparation. This study
was supported by a research grant from the Charite ´.
References
Albrektsson T, Johansson C (2001) Osteoinduction,
osteoconduction and osseointegration. Eur Spine J
10(Suppl 2):S96–101
Aspenberg P, Lindqvist SB (1998) Ethene oxide and bone
induction. Controversy remains. Acta Orthop Scand
69:173–176
Blum B, Moseley J, Miller L, Richelsoph K, Haggard W
(2004) Measurement of bone morphogenetic proteins
and other growth factors in demineralized bone ma-
trix. Orthopedics 27: s161–s165
Bolander ME (1992) Regulation of fracture repair by
growth factors. Proc Soc Exp Biol Med 200:165–170
Bright RW (1987) Sterilization of human bone by irradi-
ation. In: Friedlaender G (ed) Osteochondral allo-
grafts, biology, banking and clinical application. Little
Brown, Boston, Toronto, pp 223–232
112 Cell Tissue Banking (2007) 8:107–114
123Geesink RG (2002) Osteoconductive coatings for total
joint arthroplasty. Clin Orthop Relat Res
Feb(395):53–65
HansenA,PrussA,GollnickK,BochentinB,DennerK,Von
VersenR(2001)Demineralizedbonematrix-stimulated
bone regeneration in rats enhanced by an angiogenic
dipeptide derivate. Cell Tissue Bank 2:69–75
Haynert W (1990) Application possibilities of human
bone-collagen substance as a transplant in skeletal
surgery. Beitr Orthop Traumatol 37:453–461
Hofmann C, von Garrel T, Gotzen L (1996) Bone bank
management using a thermal disinfection system
(Lobator SD-1). A critical analysis. Unfallchirurg
99:498–508
Honsawek S, Powers RM, Wolﬁnbarger L (2005)
Extractable bone morphogenetic protein and corre-
lation with induced new bone formation in an in vivo
assay in the athymic mouse model. Cell Tissue Bank
6:13–23
International Atomic Energy Agency (IAEA) (1990)
Guidelines for industrial radiation sterilization of
disposable medical products (Cobalt-60 Gamma
Irradiation). IAEA-TECDOC-539 Vienna: IAEA 39
Knaepler H, von Garrel T, Gotzen L (1994) Untersuchun-
gen zur Desinfektion und Sterilisation allogener Kno-
chentransplantate. Hefte z d Unfallchirug 235:1–101
Kubler N, Michel C, Zoller J, Bill J, Muhling J, Reuther J
(1995) Repair of human skull defects using osteoin-
ductive bone alloimplants. J Craniomaxillofac Surg
23:337–346
Kuhls R, Werner-Rustner M, Kuchler I, Soost F (2001)
Human demineralised bone matrix as a bone sub-
stitute for reconstruction of cystic defects of the lower
jaw. Cell Tissue Bank 2:143–153
Laitinen M, Jortikka L, Halttunen T, Nevalainen J,
Aho AJ, Marttinen A, Lindholm TS (1997) Mea-
surement of total and local bone morphogenetic
protein concentration in bone tumours. Int Orthop
21:188–193
Lane JM, Tomin E, Bostrom MP (1999) Biosynthetic bone
grafting. Clin Orthop Relat Res Oct(367 Suppl):S107–
S117
Lind M, Bunger C (2001) Factors stimulating bone for-
mation. Eur Spine J 10(Suppl 2):S102–S109
Lohmann CH, Andreacchio D, Koster G, Carnes DL Jr.,
Cochran DL, Dean DD, Boyan BD, Schwartz Z
(2001) Tissue response and osteoinduction of human
bone grafts in vivo. Arch Orthop Trauma Surg
121:583–590
Moreau MF, Gallois Y, Basle MF, Chappard D (2000)
Gamma irradiation of human bone allografts alters
medullary lipids and releases toxic compounds for
osteoblast-like cells. Biomaterials 21:369–376
Pepene CE, Seck T, Diel I, Minne HW, Ziegler R,
Pfeilschifter J (2004) Concentration of insulin-like
growth factor (IGF)-I in iliac crest bone matrix in
premenopausal women with idiopathic osteoporosis.
Exp Clin Endocrinol Diabetes 112:38–43
Pinholt EM, Solheim E (1998) Osteoinductive potential of
demineralized rat bone increases with increasing
donor age from birth to adulthood. J Craniofac Surg
9:142–146
Pruss A, Gobel UB, Pauli G, Kao M, Seibold M, Monig
HJ, Hansen A, Von Versen R (2003) Peracetic acid–
ethanol treatment of allogeneic avital bone tissue
transplants – a reliable sterilization method. Ann
Transplant 8:34–42
Pruss A, Hansen A, Kao M, Gurtler L, Pauli G, Benedix F,
Von Versen R (2001) Comparison of the efﬁcacy of
virus inactivation methods in allogeneic avital bone
tissue transplants. Cell Tissue Bank 2:201–215
Pruss A, Perka C, Degenhardt P, Maronna U, Buttner-
Janz K, Paul B, Muller K, Klumpp C, Bruck JC, Von
Versen R (2002) Clinical efﬁcacy and compatibility of
allogeneic avital tissue transplants sterilized with a
peracetic acid/ethanol mixture. Cell Tissue Bank
3:235–243
Ripamonti U, Petit JC, Moehl T, van den HB, van Wyk J
(1993) Immediate reconstruction of massive cranio-
orbito-facial defects with allogeneic and alloplastic
matricesinbaboons.JCraniomaxillofacSurg21:302–308
Rock MG (1991) Biomechanics of allografts. In: Czitrom
AA, Winkler H (eds) Orthopedic allograft survey.
Springer, Wien, New York, pp 29–37
Sampath TK, Reddi AH (1981) Dissociative extraction
and reconstitution of extracellular matrix components
involved in local bone differentiation. Proc Natl Acad
Sci USA 78:7599–7603
Sasso RC, Lehuec JC, Shaffrey C (2005) Iliac crest bone
graft donor site pain after anterior lumbar interbody
fusion: a prospective patient satisfaction outcome
assessment. J Spinal Disord Tech 18:S77–S81
Schliephake H (2002) Bone growth factors in maxillofacial
skeletal reconstruction. Int J Oral Maxillofacial Surg
31:469–484
Silber JS, Anderson DG, Daffner SD, Brislin BT, Leland
JM, Hilibrand AS, Vaccaro AR, Albert TJ (2003)
Donor site morbidity after anterior iliac crest bone
harvest for single-level anterior cervical discectomy
and fusion. Spine 28:134–139
Skaggs DL, Samuelson MA, Hale JM, Kay RM, Tolo VT
(2000) Complications of posterior iliac crest bone
grafting in spine surgery in children. Spine 25:2400–
2402
Sprossig M, Mucke H (1968) On the antimicrobial effect of
peracetic acid. 5. Studies on the virucidal effect.
Pharmazie 23:665–667
Stiehl JB (2004) Revascularization of a total bulk acetab-
ular allograft at 14 years. J Arthroplasty 19:508–512
Taira H, Moreno J, Ripalda P, Forriol F (2004) Radio-
logical and histological analysis of cortical allografts:
an experimental study in sheep femora. Arch Orthop
Trauma Surg 124:320–325
Thielicke U, Thielicke B, Von Versen R, Denner K (1990)
Clinical study on the application of demineralized
bone matrix (DBM) in surgical orthodontics. Beitr
Orthop Traumatol 37:461–465
Thoren K, Aspenberg P (1995) Ethylene oxide steriliza-
tion impairs allograft incorporation in a conduction
chamber. Clin Orthop Relat Res Sep(318):259–264
Cell Tissue Banking (2007) 8:107–114 113
123von Versen R, Heider H, Kleemann I, Starke R (1992)
Chemische Sterilisation biologischer Implantate mit
einer Kombinationsmethode. Osteologie aktuell
VII:380–386
Wutzler P, Sauerbrei A (2000) Virucidal efﬁcacy of a
combination of 0.2% peracetic acid and 80% (v/v)
ethanol (PAA–ethanol) as a potential hand disinfec-
tant. J Hosp Infect 46:304–308
Zhang Q, Cornu O, Delloye C (1997) Ethylene oxide does
not extinguish the osteoinductive capacity of demin-
eralized bone. A reappraisal in rats. Acta Orthop
Scand 68:104–108
114 Cell Tissue Banking (2007) 8:107–114
123